Sökresultat - E. Yu. Andreenko
- Visas 1 - 20 av 24 resultat
- Gå till nästa sida
-
1
"They are closely interconnected, complement each other and pass into each other, there are no clear boundaries between them". Case report av E. A. Rogozhkina, A. I. Ershova, E. Yu. Andreenko, S. A. Beregovskaya
Publicerad 2023-06-01Hereditary angioedema is a rare (1:50,000) hereditary chronic disease from the group of primary immunodeficiencies, which manifests in the form of recurrent skin and mucous membrane edema of the respiratory tract and gastrointestinal tract.Pathogenesis of this disease are associated with an increase...
Hämta fulltext
Artikel -
2
Prognostic role of hemostasis-regulating genetic factors and their interaction with conventional risk factors at the early stages of coronary heart disease development av E. Yu. Andreenko, L. M. Samokhodskaya, A. V. Balatskyi, P. I. Makarevich, S. A. Boytsov
Publicerad 1970-01-01Aim. To investigate the prognostic role of selected single nucleotide polymorphisms in hemostasis-regulating genes and to clarify their interaction with conventional risk factors, RF (smoking, arterial hypertension (AH), hypercholesterolemia (HCH), obesity (O)) at the early stages of coronary heart...
Hämta fulltext
Artikel -
3
Pericardium is removed, but the anasarca remains. Multidisciplinary management of constrictive pericarditis: a case report av Z. N. Sukmarova, L. A. Matskevich, E. Yu. Andreenko, S. A. Beregovskaya, O. B. Maksimova, E. P. Evseev, T. G. Nikityuk, O. M. Drapkina
Publicerad 2025-03-01A case of a 70-year-old male patient is presented, in whom constrictive-effusive pericarditis debuted after vaccination against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), and over the six months progressed in edema and ascites, refractory to therapy. A year later, after coronavir...
Hämta fulltext
Artikel -
4
Combinations of NOS3 and CYBA alleles and essential hypertension risk in men av P. I. Makarevich, E. Yu. Andreenko, A. V. Balatsky, A. V. Kolotvin, N. O. Popova, E. B. Yarovaya, L. M. Samokhodskaya, V. A. Tkachuk
Publicerad 2010-06-01Aim. To study the role of Glu298Asp and C242T point substitutions and their combinations in the development of essential arterial hypertension (AH). Material and methods. The study included 511 men aged 19—61 years (mean age 36,2±5,5 years): 409 patients with confirmed AH diagnosis (main group, MG),...
Hämta fulltext
Artikel -
5
Remote outcomes in patients with cardiovascular diseases in outpatient practice: data from a 10-year follow-up within the RECVAZA registry av M. M. Luk'yanov, S. Yu. Martsevich, S. S. Yakushin, E. Yu. Andreenko, K. G. Pereverzeva, A. N. Kozminsky, E. A. Pravkina, V. G. Klyashtorny, O. M. Drapkina
Publicerad 2025-02-01Aim. To evaluate outcomes over 10-year follow-up and risks of adverse events in patients with cardiovascular disease (CVD) within the outpatient registry.Material and methods. In the RECVAZA outpatient registry based on 3 Ryazan clinics, 3690 patients with CVD (age, 66,1±12,9 years; men, 28,0%) were...
Hämta fulltext
Artikel -
6
Young ambulatory patients with cardiovascular diseases: age and gender characteristics, comorbidity, medication and outcomes (according to RECVASA register) av E. Yu. Andreenko, M. M. Lukyanov, S. S. Yakushin, A. N. Vorobyev, E. V. Kudryashov, I. S. Yavelov, V. G. Klyashtorny, K. G. Pereverzeva, S. A. Boytsov, O. M. Drapkina
Publicerad 2019-12-01Aim. To assess age and gender characteristics and determine comorbidity, medication, and outcomes in young ambulatory patients with cardiovascular diseases (CVD) within the framework of an ambulatory prospective registry.Material and methods. The study included 3690 patients with hypertension (HTN),...
Hämta fulltext
Artikel -
7
Outpatient-Polyclinic Register of the Multidisciplinary Medical Center (TERRA): general characteristics and first results av M. M. Lukyanov, E. Yu. Andreenko, A. A. Smirnov, M. M. Kudryavtseva, N. N. Kuzina, V. G. Klyashtorny, R. N. Shepel, L. N. Ryzhakova, O. M. Drapkina
Publicerad 2023-07-01Aim. To describe the experience of creating the Outpatient-Polyclinic Register of the Multi-specialty Medical Center (TERRA) and the first results of the study.Material and methods. The TERRA registry included 32264 patients (age 44,0±15,3 years; 32,2% men) who applied to the multidisciplinary medic...
Hämta fulltext
Artikel -
8
Early cardiovascular multimorbidity in out- and in-patient care: age characteristics and medication therapy (data from the REKVAZA and REKVAZA-CLINIC registries) av E. Yu. Andreenko, M. M. Lukyanov, S. S. Yakushin, A. N. Makoveeva, A. N. Vorobiev, K. G. Pereverzeva, E. V. Kudryashov, V. G. Klyashtorny, V. A. Dindikova, A. A. Smirnov, S. A. Boytsov, O. M. Drapkina
Publicerad 2020-11-01Aim. To assess the age and sex characteristics, comorbidities and medication therapy in patients with early cardiovascular multimorbidity in out- and in-patient care.Material and methods. The REKVAZA registry includes 3,690 patients with hypertension (HTN), coronary artery disease (CAD), heart failu...
Hämta fulltext
Artikel -
9
THE SPECIFICS OF NONCOMPACTED CARDIOMYOPATHY MANIFESTATION av R. P. Myasnikov, O. V. Blagova, O. V. Kulikova, E. A. Mershina, M. S. Kharlap, E. Yu. Andreenko, S. N. Koretsky, S. E. Serdyuk, E. V. Bazaeva, I. A. Virabova, S. A. Beregovskaya, V. E. Sinitsyn, S. A. Boytsov
Publicerad 2015-10-01Noncompacted myocardium of the left ventricle (NMLV), or noncompacted cardiomyopathy, according to the World Health Organization classification is a non-classified cardiomyopathy with not fully known origins. This type of cardiomyopathy presents with an increased trabecularity with deep intertrabecu...
Hämta fulltext
Artikel -
10
PATIENTS WITH COMBINATION OF CHRONIC HEART FAILURE, HYPERTENSION AND HISTORY OF MYOCARDIAL INFARCTION: CLINICAL AND ANAMNESTIC CHARACTERISTICS, ADMINISTRATION OF ACE INHIBITORS, AN... av M. M. Loukianov, A. N. Kozminsky, S. Yu. Martsevich, S. S. Yakushin, A. N. Vorobyev, A. V. Zagrebelnyy, R. P. Myasnikov, K. G. Pereverzeva, E. A. Pravkina, E. Yu. Andreenko, E. N. Belova, A. D. Deev, V. G. Klyashtorny, E. V. Kudryashov, S. A. Boytsov
Publicerad 2017-05-01Aim. To assess the clinical and anamnestic characteristics, the prescription rate of angiotensin converting enzyme inhibitors (ACEI)/angiotensin receptor blockers (ARB) and β-blockers in the outpatient practice, adherence to drug therapy in patients with a combination of chronic heart failure (CHF),...
Hämta fulltext
Artikel -
11
OUTPATIENT REGISTER OF CARDIOVASCULAR DISEASES IN THE RYAZAN REGION (RECVASA): PRINCIPAL TASKS, EXPERIENCE OF DEVELOPMENT AND FIRST RESULTS av S. A. Boytsov, S. S. Yakushin, S. Yu. Martsevich, M. M. Lukyanov, N. N. Nikulina, A. V. Zagrebelny, A. N. Vorobyov, K. G. Pereverseva, E. A. Pravkina, A. D. Deev, E. Yu. Andreenko, A. I. Ershova, A. N. Meshkov, R. P. Myasnikov, S. E. Serdyuk, М. S. Kharlap
Publicerad 2015-09-01Aim. To estimate risk factors and comorbidity structure, cardiovascular diseases outcomes, evaluate their diagnostics and treatment quality in real outpatient practice using a register of patients with arterial hypertension (HT), ischemic heart disease (IHD), chronic heart failure (CHF) and atrial f...
Hämta fulltext
Artikel -
12
Two-year outcomes in patients after hospitalization for COVID-19: data from the TARGET-VIP registry av M. M. Lukyanov, E. Yu. Andreenko, S. Yu. Martsevich, N. P. Kutishenko, V. P. Voronina, V. A. Dindikova, N. A. Dmitrieva, M. M. Kudryavtseva, O. V. Lerman, A. N. Makoveeva, E. Yu. Okshina, A. A. Pulin, А. А. Smirnov, V. G. Klyashtorny, O. E. Karpov, O. M. Drapkina
Publicerad 2023-11-01Aim. To evaluate 24-month outcomes after hospital treatment of patients with coronavirus disease 2019 (COVID-19) in a prospective registry.Material and methods. Two-year outcomes (2,2±0,5) after hospital treatment for COVID-19 were analyzed in 802 patients (mean age, 59,8±14,5 years, men, 51,0%). We...
Hämta fulltext
Artikel -
13
CARDIOVASCULAR DISEASES REGISTRY (RECVAZA): DIAGNOSTICS, CONCOMITANT CARDIOVASCULAR PATHOLOGY, COMORBIDITIES AND TREATMENT IN THE REAL OUTPATIENT-POLYCLINIC PRACTICE av S. A. Boytsov, M. M. Luk’yanov, S. S. Yakushin, S. Yu. Martsevich, A. N. Vorobyov, A. V. Zagrebelny, K. G. Pereverzeva, E. A. Pravkina, A. D. Deev, E. Yu. Andreenko, A. I. Ershova, A. N. Meshkov, R. P. Myasnikov, S. S. Serdyuk, M. S. Kharlap, E. V. Bazaeva, A. N. Kozminsky, K. A. Moseychuk, E. N. Kudryashov
Publicerad 2014-12-01Aim. To study the structure of concomitant cardiovascular and comobid pathology, risk factors in patients with arterial hypertension (AH), coronary heart disease (CHD), with congestive heart failure (CHF) and atrial fibrillation (AF), and to evaluate the quality of diagnostics and treatment in the c...
Hämta fulltext
Artikel -
14
Long-term outcomes in patients after COVID-19: data from the TARGET-VIP registry av M. M. Lukyanov, N. P. Kutishenko, S. Yu. Martsevich, A. A. Pulin, E. Yu. Andreenko, V. P. Voronina, V. A. Dindikova, N. A. Dmitrieva, O. V. Lerman, A. N. Makoveeva, E. Yu. Okshina, A. S. Sgibneva, A. A. Smirnov, E. N. Belova, V. G. Klyashtorny, E. V. Kudryashov, O. E. Karpov, O. M. Drapkina
Publicerad 2022-04-01Aim. To assess long-term outcomes within 12 months after hospital treatment of patients with coronavirus disease 2019 (COVID-19) as part of a prospective registry.Material and methods. Outcomes in the posthospital period were assessed in 827 patients diagnosed with COVID-19 (age, 58,0±14,8 years; me...
Hämta fulltext
Artikel -
15
THE OUTPATIENT BASED REGISTRY RECVASA: PROSPECTIVE FOLLOW-UP DATA, RISK EVLUATION AND OUTCOMES IN CARDIOVASCULAR PATIENTS av S. A. Boytsov, М. М. Lukyanov, S. S. Yakushin, S. Yu. Martsevich, A. N. Vorobyev, A. V. Zagrebelny, K. G. Pereverzeva, Е. А. Pravkina, A. D. Deev, E. Yu. Andreenko, A. I. Ershova, A. N. Meshkov, R. P. Myasnikov, S. S. Serdyuk, M. S. Kharlap, E. V. Bazaeva, A. N. Kozminsky, K. A. Moseychuk, V. G. Klyashtorny, E. V. Kudryashov
Publicerad 2015-02-01Aim. To evaluate, under the frame of prospective registry, the 12-month outcomes and risks in patients with arterial hypertension (AH), ischemic heart disease (CHD), chronic heart failure (CHF) and atrial fibrillation (AF) in the real outpatient practice in Ryazan Region. Material and methods. Into...
Hämta fulltext
Artikel -
16
Medical treatment of cardiovascular diseases in patients after hospitalization for COVID-19 (three-year follow-up data in the TARGET-VIP registry) av N. P. Kutishenko, S. Yu. Martsevich, M. M. Loukianov, E. Yu. Andreenko, V. P. Voronina, V. A. Dindikova, N. A. Dmitrieva, M. M. Kudryavtseva, O. V. Lerman, E. Yu. Okshina, A. A. Smirnov, A. G. Soplenkova, A. A. Pulin, N. N. Kuzina, D. A. Nefedova, V. G. Klyashtorniy, O. E. Karpov, O. M. Drapkina
Publicerad 2025-01-01Aim. To evaluate the quality of drug treatment of patients with cardiovascular diseases (CVD) at the remote stage of follow-up after hospitalization for new coronavirus infection (COronaVIrus Disease 2019, COVID-19) within the framework of the prospective TARGET-VIP registry.Material and methods. 1,...
Hämta fulltext
Artikel -
17
Medical treatment of patients with cardiovascular diseases during the first year after hospitalization for COVID-19 av N. P. Kutishenko, M. M. Lukyanov, S. Yu. Martsevich, A. A. Pulin, E. Yu. Andreenko, V. P. Voronina, V. A. Dindikova, N. A. Dmitrieva, M. M. Kudryavtseva, O. V. Lerman, A. N. Makoveeva, E. Yu. Okshina, А. А. Smirnov, E. N. Belova, V. G. Klyashtorny, E. V. Kudryashov, O. E. Karpov, O. M. Drapkina
Publicerad 2023-01-01Aim. To evaluate the medical treatment of patients with cardiovascular disease (CVD) during the first year of follow-up after hospitalization for coronavirus disease 2019 (COVID-19) in a prospective registry.Material and methods. The material for the study was obtained from the database of the TARGE...
Hämta fulltext
Artikel -
18
Prehospital Period in Patients with COVID-19: Cardiovascular Comorbidity and Pharmacotherapy During the First Epidemic Wave (Hospital Registry Data) av S. Yu. Martsevich, M. M. Lukyanov, M. M. Pulin, N. P. Kutishenko, E. Yu. Andreenko, V. P. Voronina, V. A. Dindikova, N. A. Dmitrieva, A. V. Zagrebelnyy, O. V. Lerman, A. N. Makoveeva, E. Yu. Okshina, A. A. Smirnov, E. V. Kudryashov, I. V. Budaeva, E. S. Nikoshnova, O. E. Karpov, O. M. Drapkina
Publicerad 2022-01-01Aim. Based on the data from the register of patients with COVID-19 and community-acquired pneumonia (CAP), analyze the duration of the prehospital period, cardiovascular comorbidity and the quality of prehospital pharmacotherapy of concomitant cardiovascular diseases (CVD).Material and methods. Pati...
Hämta fulltext
Artikel -
19
Dynamics of age characteristics and prevalence of concomitant cardiovascular and non-sardiovascular diseases in patients hospitalized with COVID-19 during epidemic wave: data from... av M. M. Lukyanov, S. Yu. Martsevich, A. A. Pulin, N. P. Kutishenko, E. Yu. Andreenko, V. P. Voronina, V. A. Dindikova, N. A. Dmitrieva, A. V. Zagrebelny, A. N. Makoveeva, O. V. Lerman, E. Yu. Okshina, А. S. Sgibneva, A. A. Smirnov, E. N. Belova, V. G. Klyashtorny, E. V. Kudryashov, O. E. Karpov, O. M. Drapkina
Publicerad 2022-01-01Aim. According to hospital-based registry, to evaluate the age characteristics and prevalence of concomitant cardiovascular and non-сardiovascular diseases in patients hospitalized with COVID-19 during epidemic wave.Material and methods. The TARGET-VIP register included 1130 patients aged 57,5+12,8...
Hämta fulltext
Artikel -
20
Detection rate and characteristics of heart failure, depending on the diagnostic criteria in COVID-19 survivors one year after hospitalization av Yu. V. Mareev, M. M. Lukyanov, S. Yu. Martsevich, A. A. Pulin, N. P. Kutishenko, E. Yu. Andreenko, V. P. Voronina, V. A. Dindikova, N. A. Dmitrieva, A. N. Makoveeva, O. V. Lerman, E. Yu. Okshina, A. A. Smirnov, M. M. Kudryavtseva, E. N. Belova, V. G. Klyashtorny, E. V. Kudryashov, O. E. Karpov, O. M. Drapkina
Publicerad 2023-01-01Aim. To estimate the detection rate of heart failure (HF), using various diagnosis criteria, among patients aftr 12 months after hospital treatment for coronavirus disease 2019 (COVID-19).Material and methods. The study included 185 patients from the TARGET-VIP registry who came for a visit 12 month...
Hämta fulltext
Artikel